Determining how long tulathromycin stays in goats after treatment
Official title: Concentration Determination of Tulathromycin Residues (CP-60,300) in Liver and Injection Site Tissues of Goats Receiving One Subcutaneous Injection of DRAXXIN 25 (25 mg/mL) at 2.5 mg/kg Bodyweight
Funded at Iowa State University · NIH-11022650 · Data updated 2026-11-12
This study is looking at how long the antibiotic Draxxin stays in goats after they get a single shot, so we can help farmers know when it's safe to eat the meat without any leftover medicine in it, making it easier to treat goats with pneumonia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $250,000 |
| NIH project number | 1R01FD008252-01 |
| Project ID | NIH-11022650 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are goat farmers and veterinarians involved in the treatment of respiratory diseases in goats.
✕Less likely to help
Patients who do not own goats or are not involved in goat farming will not benefit from this research.
What this research studies
This research investigates the concentration of tulathromycin residues in the liver and injection sites of goats after they receive a single subcutaneous injection of the antibiotic Draxxin. The goal is to establish a scientifically-based withdrawal period for meat consumption, ensuring that the antibiotic is no longer present in the animal's system at the time of slaughter. By analyzing tissue samples, the study aims to provide veterinarians with reliable data to improve treatment protocols for bacterial pneumonia in goats. This research is particularly important as it addresses compliance issues with current treatment methods that require daily administration.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for bacterial pneumonia in goats, enhancing animal welfare and food safety.
How similar studies have gone: Similar research has shown success in establishing withdrawal periods for other veterinary drugs, indicating that this approach is both tested and valuable.
Where this research is happening
-
Iowa State University
Ames, United States Active
Researchers
- Principal investigator: Gorden, Patrick J — Iowa State University
- Study coordinator: Gorden, Patrick J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.